Hot Topic: Emerging Biomarkers for the Optimal Assessment of Global Cardiovascular Risk: Where Do We Stand? (HaralamposJ.Milionin and Moses S. Elisaf)

The Open Clinical Chemistry Journal
doi 10.2174/1874241601003010008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Editorial: Emerging Biomarkers for the Optimal Assessment of Global Cardiovascular Risk: Where Do We Stand?~!2009-11-10~!2009-12-10~!2010-04-08~!

The Open Clinical Chemistry Journal
2010English

Blockchain in Academia: Where Do We Stand and Where Do We Go?

2020English

Men?s Health: Where Do We Stand and What Lies Ahead?

Andrology-Open Access
2015English

High Energy Neutrino Astronomy: Where Do We Stand, Where Do We Go?

Physics of Particles and Nuclei
High Energy PhysicsNuclear
2018English

Schistosomiasis Vaccines: Where Do We Stand?

Parasites and Vectors
ParasitologyInfectious Diseases
2016English

Where Do We Stand After Coty?

Competition Law Journal
2018English

Quantum Computers: Where Do We Stand?

Europhysics News
AstronomyPhysics
2005English

Transplantation Tolerance: The Big Picture. Where Do We Stand, Where Should We Go?

Clinical and Experimental Immunology
AllergyImmunology
2017English

Change, Commitment, and Ethics: Where Do We Stand?

American Journal of Occupational Therapy
MedicineOccupational Therapy
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy